Abstract:Synthetic amorphous silica (SAS), in the form of pyrogenic (fumed), precipitated, gel or colloidal SAS, has been used in a wide variety of industrial and consumer applications including food, cosmetics and pharmaceutical products for many decades. Based on extensive physico-chemical, ecotoxicology, toxicology, safety and epidemiology data, no environmental or health risks have been associated with these materials if produced and used under current hygiene standards and use recommendations. With internal structures in the nanoscale size range, pyrogenic, precipitated and gel SAS are typical examples of nanostructured materials as recently defined by the International Organisation for Standardisation (ISO). The manufacturing process of these SAS materials leads to aggregates of strongly (covalently) bonded or fused primary particles. Weak interaction forces (van der Waals interactions, hydrogen bonding, physical adhesion) between aggregates lead to the formation of micrometre (μm)-sized agglomerates. Typically, isolated nanoparticles do not occur. In contrast, colloidal SAS dispersions may contain isolated primary particles in the nano-size range which can be considered nano-objects. The size of the primary particle resulted in the materials often being considered as "nanosilica" and in the inclusion of SAS in research programmes on nanomaterials. The biological activity of SAS can be related to the particle shape and surface characteristics interfacing with the biological milieu rather than to particle size. SAS adsorbs to cellular surfaces and can affect membrane structures and integrity. Toxicity is linked to mechanisms of interactions with outer and inner cell membranes, signalling responses, and vesicle trafficking pathways. Interaction with membranes may induce the release of endosomal substances, reactive oxygen species, cytokines and chemokines and thus induce inflammatory responses. None of the SAS forms, including colloidal nano-sized particles, were shown to bioaccumulate and all disappear within a short time from living organisms by physiological excretion mechanisms with some indications that the smaller the particle size, the faster the clearance is. Therefore, despite the new nomenclature designating SAS a nanomaterial, none of the recent available data gives any evidence for a novel, hitherto unknown mechanism of toxicity that may raise concerns with regard to human health or environmental risks. Taken together, commercial SAS forms (including colloidal silicon dioxide and surface-treated SAS) are not new nanomaterials with unknown properties, but are well-studied materials that have been in use for decades.

Toxicity of Spherical and Anisotropic Nanosilica

The nanosilica hazard: another variable entity

Toxicology of silica nanoparticles: an update

Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review

The toxicological mode of action and the safety of synthetic amorphous silica—A nanostructured material

Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications

Influence of Surface Charge on the Functional Properties of Silica Nanoparticles and Cellular Toxicity

Characterization of in vitro genotoxic, cytotoxic and transcriptomic responses following exposures to amorphous silica of different sizes

Influence of Geometry, Porosity, and Surface Characteristics of Silica Nanoparticles on Acute Toxicity: Their Vasculature Effect and Tolerance Threshold.

Toxicity of Sol-Gel Synthesized Silica Nanoparticles: Insights from Cellular and Model Organism Studies

Influence of shape, adhension and simulated lung mechanics on amorphous silica nanoparticle toxicity

Subtoxic cell responses to silica particles with different size and shape

Cardiovascular Toxicity of Different Sizes Amorphous Silica Nanoparticles in Rats after Intratracheal Instillation

Silica nanoparticles: Biomedical applications and toxicity

Potential Toxic Effects of Nano-Oxides

Advances in the study of silica nanoparticles in lung diseases

Toxic effect of silica nanoparticles on bronchial epithelial cells

Evaluation of the Toxicity of Food Additive Silica Nanoparticles on Gastrointestinal Cells

Study of Toxicity to Rats Induced by Nanosized SiO2 and Standard SiO2

Cytotoxicity of mesoporous silica nanomaterials

Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity.